Download video

Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma

494 views

OncLive

4 years ago

Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma

Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma

Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma
1:16
Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma
by OncLive
John P. Leonard, MD, on the FDA Approval of Tazemetostat for Follicular Lymphoma
8:58
John P. Leonard, MD, on the FDA Approval of Tazemetostat for Follicular Lymphoma
by Cancer Network
Accelerated Approval of Tazemetostat For Follicular Lymphoma
3:55
Accelerated Approval of Tazemetostat For Follicular Lymphoma
by CheckRare
Dr. Skarbnik on the Approval of Tazemetostat in Relapsed\/Refractory Follicular Lymphoma
0:57
Dr. Skarbnik on the Approval of Tazemetostat in Relapsed\/Refractory Follicular Lymphoma
by OncLive
Exploring the Tazemetostat Approval in R\/R Follicular Lymphoma
1:31
Exploring the Tazemetostat Approval in R\/R Follicular Lymphoma
by Targeted Oncology
Dr. Maddocks on the Role of Tazemetostat in EZH2-Mutant Follicular Lymphoma
1:11
Dr. Maddocks on the Role of Tazemetostat in EZH2-Mutant Follicular Lymphoma
by OncLive
Tazemetostat in combination with lenalidomide and rituximab for R\/R follicular lymphoma
1:48
Tazemetostat in combination with lenalidomide and rituximab for R\/R follicular lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. Leonard on Lenalidomide With Rituximab in Follicular Lymphoma
1:31
Dr. Leonard on Lenalidomide With Rituximab in Follicular Lymphoma
by OncLive
Andrew Zelenetz, MD, provides thoughts on the unique MOA on the newly FDA approved tazemetostat
1:57
Andrew Zelenetz, MD, provides thoughts on the unique MOA on the newly FDA approved tazemetostat
by OBRoncology
Leslie Popplewell, MD, provides thoughts on the unique MOA on the newly FDA approved tazemetostat
3:24
Leslie Popplewell, MD, provides thoughts on the unique MOA on the newly FDA approved tazemetostat
by OBRoncology
Dr. Burke on Tazemetostat’s Mechanism of Action in EZH2-Mutated Follicular Lymphoma
1:35
Dr. Burke on Tazemetostat’s Mechanism of Action in EZH2-Mutated Follicular Lymphoma
by OncLive
FDA Approval in CLL and FL, Partial Hold Lifted in Tazmetostat Trials, and More
11:13
FDA Approval in CLL and FL, Partial Hold Lifted in Tazmetostat Trials, and More
by OncLive
Tazemetostat and rituximab in r\/r follicular lymphoma
0:38
Tazemetostat and rituximab in r\/r follicular lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. John Leonard on When to Treat Patients With Follicular Lymphoma
1:07
Dr. John Leonard on When to Treat Patients With Follicular Lymphoma
by Targeted Oncology
Dr. Skarbnik on Future Combination Therapies With Tazemetostat in Follicular Lymphoma
1:08
Dr. Skarbnik on Future Combination Therapies With Tazemetostat in Follicular Lymphoma
by OncLive
Dr. Leslie on Phase 1b Trial of Tazemetostat Plus Lenalidomide\/Rituximab in Follicular Lymphoma
1:15
Dr. Leslie on Phase 1b Trial of Tazemetostat Plus Lenalidomide\/Rituximab in Follicular Lymphoma
by OncLive
Tribute to John P. Leonard, MD at the 2018 Annual Gala
6:04
Tribute to John P. Leonard, MD at the 2018 Annual Gala
by Lymphoma Research Foundation
John P. Leonard, MD, discusses novel agents for treating aggressive lymphomas
1:01
John P. Leonard, MD, discusses novel agents for treating aggressive lymphomas
by OBRoncology
John P. Leonard, MD, on the role checkpoint inhibitors play in lymphoma treatment algorithms
1:40
John P. Leonard, MD, on the role checkpoint inhibitors play in lymphoma treatment algorithms
by OBRoncology
Dr John P Leonard Live Q\&A Living with Follicular Lymphoma
1:06:04
Dr John P Leonard Live Q\&A Living with Follicular Lymphoma
by Nicky Greenhalgh